2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-04-17 |
|
2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-04-17 ±³À°ÁÖÁ¦ : 2024³â Á¦75Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ À̸ÞÀÏ : kda@derma.or.kr ±³À°Á¾·ù : ÇǺΰú Âü¼®¿¹»óÀÎ : 800¸í Áö¿ª : ºÎ»ê±¤¿ª½Ã ¼¼ºÎ¼ö°·á : 500,000¿ø ºñ°í Á¤È¸¿ø 80,000 / ÁØȸ¿ø 40,000 / ºñȸ¿ø 500,000¿ø
±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 13:10~13:30 ÃÊ·Ï Chronic actinic dermatitis: Recent report series, environment-related changes and preceding dermatologic conditions ±è±âÈ£(µ¿¾ÆÀÇ´ë) ±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 14:00~14:05 Introduction Chair(-) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 14:05~14:50 Vitiligo: News on immunopathogenesis and therapeutic perspectives Julien Seneschal(Department of Dermatology University Hospital of Bordeaux Bordeaux France) Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 14:50~15:00 Q&A -(-) ±âŸ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 10:30~10:35 Introduction Chair(-) ±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 10:35~11:20 ÃÊ·Ï How MBTI affects successful life ³ªÇضõ(³ªÇضõÁ¤½Å°Ç°ÀÇÇаú) Åä·Ð 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 11:20~11:30 Q&A -(-) ±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 15:30~15:35 Introduction Chair(-) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 15:35~16:20 ÃÊ·Ï Robot and dermatologist¡®s life ¾ÈÇý¹Î(UNIST) Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 16:20~16:30 Q&A -(-) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 10:20~10:45 ÃÊ·Ï Navigating legal landscapes and future policies in tattoo À̱¤ÁØ(Ŭ¸°¾÷ÇǺΰú) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 10:45~11:05 ÃÊ·Ï Exploring medical tattooing for the treatment of dermatological conditions Ȳ¼ºÁÖ(Ȳ¼ºÁÖÅÐÅÐÇÑÇǺΰú) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 11:05~11:20 ÃÊ·Ï Side effects of tattoos and pigments, and tattoo removal À̽ÃÇü(¼¿ïÀÇ´ë) Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 11:20~11:30 Panel discussion ( ) ±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 13:50~14:04 ÃÊ·Ï Understanding the science behind skin boosters and biostimulators ÇÑÇý¼º(Áß¾ÓÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 14:04~14:18 ÃÊ·Ï Exosomes in atopic dermatitis ¹Ú±Í¿µ(Áß¾ÓÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 14:18~14:32 ÃÊ·Ï Innovations in skin boosting technologies ÀÌ¿µÀÎ(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 14:32~14:50 ÃÊ·Ï Integrating skin boosters and biostimulators in clinical practice ±èÈ«¼®(º¸½ºÇǺΰú) Åä·Ð 04¿ù 17ÀÏ »çÆÄÀ̾î 14:50~15:00 Panel discussion (-) ±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 14:00~14:05 Overview Chair(-) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 14:05~14:20 ÃÊ·Ï Effect of climate on skin and cosmetics Á¤°æÀº(Ãæ³²ÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 14:20~14:35 ÃÊ·Ï Effect of pollution on skin and cosmetics ±èÇý¼º(°¡Å縯ÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 14:35~14:50 ÃÊ·Ï Effect of eco-friendly ingredients on skin and cosmetics ¼³Á¤Àº(ÀÎÁ¦ÀÇ´ë) Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 14:50~15:00 Q&A -(-) ±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 15:30~15:35 Overview Chair(-) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 15:35~15:50 ÃÊ·Ï Resident memory cells in vitiligo ÃÖÁ¾¿ø(¼¿ïÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 15:50~16:05 ÃÊ·Ï Resident memory cells in psoriasis ¹éÀ¯»ó(°í·ÁÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 16:05~16:20 ÃÊ·Ï Resident memory cells in atopic dermatitis ½Å±âÇõ(ºÎ»êÀÇ´ë) Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 16:20~16:30 Q&A -(-) ±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 16:30~16:35 Overview Chair(-) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 16:35~16:50 ÃÊ·Ï Skin infectious diseases related to bacteria from abroad ÀÌ¿ìÁø(¿ï»êÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 16:50~17:05 ÃÊ·Ï Skin infectious diseases related to viruses from abroad ¿ìÀ¯¸®(°¡Å縯ÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 17:05~17:20 ÃÊ·Ï Skin infectious diseases related to insects from abroad Àå¿ëÇö(°æºÏÀÇ´ë) Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 17:20~17:30 Q&A -(-) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 09:30~09:42 ÃÊ·Ï Biopsy, immunofluorescence ±èº¸¸®(¼¿ïÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 09:42~09:54 ÃÊ·Ï Bacterial and fungal examination ÀÌÁö¼ö(¼¿ïÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 09:54~10:06 ÃÊ·Ï Phototest ³²°æÈ(ÀüºÏÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 10:06~10:18 ÃÊ·Ï Patch and prick tests ÀÌÁ¤¼ö(ºÎ»êÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 10:18~10:30 ÃÊ·Ï Dermoscopy ¹Ú»óÇö(°¡ÃµÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 10:30~10:42 ÃÊ·Ï Steroids, anti-inflammatory drugs ¼®ÁØ(Áß¾ÓÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 10:42~10:54 ÃÊ·Ï Immunosuppressants ¿ìÀ¯¸®(°¡Å縯ÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 10:54~11:06 ÃÊ·Ï Retinoids ÃÖÈÆ(Á¶¼±ÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 11:06~11:18 ÃÊ·Ï Antihistamines, anti-itch agents ±Ç¼øÈ¿(°æÈñÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 11:18~11:30 ÃÊ·Ï Antibiotics, antifungals ¼Çö¹Î(ÇѾçÀÇ´ë) ±âŸ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 09:30~09:35 Overview Chair(-) ±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 09:35~09:50 ÃÊ·Ï Recent issues regarding to ocular safety »çÈ£¼®(¿ï»êÀÇ´ë ¾È°ú) ±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 09:50~10:05 ÃÊ·Ï Practical tips during laser surgery for safety ÀÌÁ¾Èñ(¼º±Õ°üÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 10:05~10:20 ÃÊ·Ï Laser safety use guidance ¼Çö¹Î(ÇѾçÀÇ´ë) Åä·Ð 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 10:20~10:30 Q&A -(-) ±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 15:30~15:45 ÃÊ·Ï Fundamentals of energy-based devices for pigmentary disorders ÃÖ¼ö¿µ(º¦¿¤ÇǺΰú) ±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 15:45~16:00 ÃÊ·Ï Upgrade your vitiligo treatment with micropunch grafting ¹èÁ¤¹Î(ÈúÇϿ콺ÇǺΰú) ±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 16:00~16:15 ÃÊ·Ï Multimodal scar treatment: Basic principles and key techniques ¼Û¸¶°¡·¿(ÁöÀ¯³×ÇǺΰú) ±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 16:15~16:30 ÃÊ·Ï Botulinum toxin: The essentials from the beginning ¼Á¾±Ù(¾ÆÄ«µ¥¹ÌÇǺΰú) ±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 16:30~16:45 ÃÊ·Ï Elevating dermatology: New world of RF and HIFU skin lifting Àü¼ö¿µ(ºû³ª¶óÇǺΰú) Åä·Ð 04¿ù 17ÀÏ »çÆÄÀ̾î 16:45~17:00 Q&A -(-) ±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 09:30~09:35 Introduction Chair(-) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 09:35~09:55 ÃÊ·Ï Terminology in scholarly publication À±Çö¼±(¼¿ïÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 09:55~10:15 ÃÊ·Ï Evaluation process of scopus and web of science ÀÌ¿µº¹(°¡Å縯ÀÇ´ë) Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 10:15~10:20 Q&A -(-) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 16:30~17:20 ÃÊ·Ï Anti-skin aging strategy Á¤ÁøÈ£(¼¿ïÀÇ´ë) Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 17:20~17:30 Q&A -(-) ±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 15:30~15:50 ÃÊ·Ï Function and chemical modulation of autophagy: Its therapeutic application for melanosome degradation ±Ç¿ëÅÂ(¼¿ïÀÇ´ë ÀÇ°úÇаú) ±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 15:50~16:10 ÃÊ·Ï Autophagy and melanocytes senescence: A new frontier in photoaging °Èñ¿µ(¾ÆÁÖÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 16:10~16:30 ÃÊ·Ï The role of autophagy in the pigmentation ¿À»óÈ£(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 16:30~16:50 ÃÊ·Ï Fibroblasts and autophagy in persistent PIH À̽ÃÇü(¼¿ïÀÇ´ë) Åä·Ð 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 16:50~17:00 Q&A -(-) ±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 13:30~13:35 Introduction Chair(-) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 13:35~13:55 ÃÊ·Ï Analyzing uncommon skin cancers in Koreans: EMPD, angiosarcoma, Kaposi¡¯s sarcoma, and DFSP ÇÏ´ë·æ(°æºÏÀÇ´ë) Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 13:55~14:00 Q&A -(-) ±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 13:30~13:35 Introduction Chair(-) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 13:35~13:55 ÃÊ·Ï The interplay between skin and intestinal diseases ¹ÚÇö¼±(¼¿ïÀÇ´ë) Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 13:55~14:00 Q&A -(-) ±âŸ 04¿ù 17ÀÏ »çÆÄÀ̾î 17:00~17:05 Overview -(-) ±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 17:05~17:20 ÃÊ·Ï Inflammatory diseases on hands and feet ±èÁ¤Àº(°¡Å縯ÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 17:20~17:35 ÃÊ·Ï Benign tumors on hands and feet ÇÏ´ë·æ(°æºÏÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ »çÆÄÀ̾î 17:35~17:50 ÃÊ·Ï Malignant tumors on hands and feet ÀÌ¿ìÁø(¿ï»êÀÇ´ë) Åä·Ð 04¿ù 17ÀÏ »çÆÄÀ̾î 17:50~18:00 Q&A -(-) ±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 11:30~11:35 Introduction -(-) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 11:35~12:10 ÃÊ·Ï Pioneering early intervention in psoriasis with secukinumab: STEPIn core and mechanistic study ¹ÚÀºÁÖ(ÇѸ²ÀÇ´ë) Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëAB 12:10~12:30 Q&A -(-) ±âŸ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 11:30~11:35 Introduction -(-) ±³À°½Ã°£ 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 11:35~12:10 ÃÊ·Ï Can we control the emergence of PsA? ¹æöȯ(°¡Å縯ÀÇ´ë) Åä·Ð 04¿ù 17ÀÏ Å©¸®½ºÅ»º¼·ëC 12:10~12:30 Q&A -(-) ±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 14:00~14:25 ÃÊ·Ï Accelerate breakthroughs in atopic dermatitis with abrocitinib ÀüÁöÇö(°í·ÁÀÇ´ë) ±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 14:25~14:50 ÃÊ·Ï Guidance on leveraging AD treatment to improve outcomes ¿øÁ¾Çö(¿ï»êÀÇ´ë) Åä·Ð 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 14:50~15:00 Q&A -(-) ±³À°½Ã°£ 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 17:00~17:40 ÃÊ·Ï Optimal strategy of long-term AGA treatment with Dutasteride 0.5mg ¹Ú¼ÒÈñ(¿¬¼¼ÀÇ´ë) Åä·Ð 04¿ù 17ÀÏ ¿¡¸Þ¶öµå 17:40~18:00 Q&A -(-)
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|
Á¦¸ñ |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 570 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 945 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 713 , ´ñ±Û¼ö : 1 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 552 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 702 , ´ñ±Û¼ö : 0 |